Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Reviews in endocrine & metabolic disorders·2026
Same author

Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update.

Nature medicine·2026
Same author

Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Reviews in endocrine & metabolic disorders·2026
Same author

Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional Perspective.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Preliminary Study on Circulating REG3α and Its Associations with Vitamin D Supplementation and Inflammatory Biomarkers in Adults with Overweight and Obesity.

Current issues in molecular biology·2026
Same author

Efficacy and Safety of Pharmacological, Endoscopic, and Surgical Treatments for Obesity: A GRADE-Based Network Meta-Analysis.

Obesity (Silver Spring, Md.)·2026

Related Experiment Video

Updated: Jun 20, 2026

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting
08:28

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting

Published on: June 30, 2017

9.5K

Adipogenic progenitors in different organs: Pathophysiological implications.

Francesca Favaretto1, Silvia Bettini1, Luca Busetto1

  • 1Department of Medicine, Internal Medicine 3, University of Padua, via Giustiniani 2, 35128, Padua, Italy.

Reviews in Endocrine & Metabolic Disorders
|October 30, 2021
PubMed
Summary
This summary is machine-generated.

Dysfunctional adipose tissue, including ectopic fat, contributes to metabolic disorders like insulin resistance and type 2 diabetes. Targeting these fat depots is crucial for preventing obesity-related complications.

Keywords:
Adipose tissueAdipose tissue-derived stromal and stem cells (ASCs)AdiposopathyIntermuscular adipose tissue (IMAT)Mesenchymal stromal cells (MSCs)ObesitySignaling

More Related Videos

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

12.0K
Preparation of Adipose Progenitor Cells from Mouse Epididymal Adipose Tissues
06:17

Preparation of Adipose Progenitor Cells from Mouse Epididymal Adipose Tissues

Published on: August 25, 2020

5.9K

Related Experiment Videos

Last Updated: Jun 20, 2026

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting
08:28

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting

Published on: June 30, 2017

9.5K
Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

12.0K
Preparation of Adipose Progenitor Cells from Mouse Epididymal Adipose Tissues
06:17

Preparation of Adipose Progenitor Cells from Mouse Epididymal Adipose Tissues

Published on: August 25, 2020

5.9K

Area of Science:

  • Metabolic physiology
  • Cellular biology
  • Endocrinology

Background:

  • Adipose tissue is a dynamic endocrine organ regulating energy metabolism.
  • It comprises adipocytes, adipose-derived stromal/stem cells (ASCs), and immune/endothelial cells.
  • Dysfunctional adipose tissue in obesity and aging leads to inflammation and insulin resistance.

Purpose of the Study:

  • To review the presence and precursors of adipose tissue in non-traditional locations (ectopic fat).
  • To explore interactions driving the development of organ pathologies linked to dysfunctional adipose tissue.
  • To highlight the role of adipose tissue in metabolic diseases.

Main Methods:

  • Literature review focusing on adipose tissue biology, ectopic fat, and metabolic disease.
  • Analysis of cellular composition and differentiation of adipose precursors.
  • Examination of pathological mechanisms in obesity-related diseases.

Main Results:

  • Obesity alters ASCs, impairing adipose tissue function and promoting systemic inflammation.
  • Ectopic adipose tissue forms in organs like the heart and liver when normal depots reach capacity.
  • Ectopic fat shares characteristics with dysfunctional adipose tissue, increasing disease risk.

Conclusions:

  • Dysfunctional adipose tissue, particularly ectopic fat, is implicated in insulin resistance, type 2 diabetes, and cardiovascular disease.
  • Understanding adipose tissue precursors and their interactions is key to preventing metabolic complications.
  • Targeting dysfunctional adipose tissue offers a strategy to mitigate obesity-related health issues.